CD24 and neoplasm: As for BC0244 xenograft tumor cells, 83.8% and 54% of IGF1Rhi were CD24--CD44+and ALDH+, respectively, as compared with 48.7% and 31.9% of IGF-1Rlo cells, respectively (Figure 1C, lower panel).